Rafferty Asset Management
NEO icon

Rafferty Asset Management’s NeoGenomics NEO Stock Holding History

Rafferty Asset Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-27,447
Closed -$562K – 836
2019
Q1 		$562K Buy
+27,447
New +$477K 0.01% 647

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Rafferty Asset Management's NEO Position: Q2 2019 in Review

Rafferty Asset Management sold out of NeoGenomics (NEO) in Q2 2019, closing a stake of 27,447 shares — an estimated $562K sold.

Rafferty Asset Management first reported a position in NEO in Q1 2019 and held it in 1 quarter. The position peaked at $562K in Q1 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q2 2019.

  • Rafferty Asset Management reported no remaining NeoGenomics position as of Q2 2019 after selling out during the quarter.
  • Rafferty Asset Management sold 27,447 NeoGenomics shares in Q2 2019, an estimated $562K.
  • Rafferty Asset Management first reported a position in NeoGenomics in Q1 2019 and held it in 1 quarter.
  • Rafferty Asset Management's NeoGenomics position peaked at $562K in Q1 2019.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2019.

Based on Rafferty Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.